A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.
J Exp Med. 2022 Jan 3;219(1):e20202084. doi: 10.1084/jem.20202084. Epub 2021 Nov 22.
J Exp Med. 2022.
PMID: 34807232
Free PMC article.